Research On CelLynx By Analyst VassalottiI like this company:
Investrend ‘Discovery’ Research On CelLynx By Analyst Vassalotti
2009-12-21 08:26 ET - News Release
NEW YORK -- (Business Wire)
Investrend Equity Research has issued a 7-page “Discovery” ResearchReport on CelLynx Group, Inc. (OTCBB: CYNX) dated December 18, 2009,written by independent analyst Gary Vassalotti, LIFA, focusing on thecompany's “5BARz” cell phone signal amplification device, as well as theproduction, product placement and distribution of the device. The reportis also based on analyst Vassalotti’s personal experience using the5BARz device.
The full report includes important disclosures, disclaimers and analystinformation. Investrend advises investors to exercise a reasonabledegree of due diligence before trading in the equities of any publiccompany, including carefully reading entire analyst reports and reportdisclosures, and then only in conjunction with advice from a registeredfinancial advisor or broker. Investrend further advises that any analystrating, recommendation, target valuation, price target or opinion shouldbe considered merely a portion of an investor’s total investigativeprocess. (More about ratings and valuations is available at https://www.investrend.com/ratings).
A complementary report, which includes complete disclosures, disclaimersand analyst qualifications, is available for download via the InvestrendSyndications website (https://www.investrend.com/research/cynx).
According to analyst Vassalotti’s report:
“The company has completed its pilot production run, and the units havebeen qualified. Commercial production has already started. With thesetwo milestones passed, CYNX is now eligible to receive the first of aseries of License fees paid by Dollardex, Inc.
“CYNX has signed a contract manufacturing agreements with a leadingAsian firm, Pacific Spectrum Technologies Solutions, who will build the5BARz boosters. That agreement will provides CYNX with up to 30,000units per month.
“CYNX has signed an international distribution agreement with Dollardex,Inc., a Panamanian company, to distribute the Company's products outsideof the US. That agreement, along with in-place private placementagreements, provides for adequate financing of the company during therevenue slow startup period.
“The RepeaterStore.com, a leading e-commerce retailer in the wirelessbooster market, has agreed to an initial purchase of 10,000 units of thecompany's 5BARz mobile unit. RepeaterStore.com will also develop adedicated e-commerce site just for the CelLynx product, titled‘CelLynxStore.com’.
“Initial production of the 'Road Warrior' unit has commenced and thecontract manufacturer is beginning to fill the (previously mentioned)10,000-unit initial order.”
About CelLynx:
CelLynx Group, Inc. produces and markets plug-and-play cell phone signalamplification technology. It offers CelLynx 5BARz Road Warrior, a singlepiece device that strengthens weak cellular signals to deliver higherquality signals for voice, data, and video reception on cell phonesbeing used indoors or in vehicles. The company was founded in 2005 andis headquartered in Mission Viejo, California.
About Investrend and Discovery Research
Investrend Communications, Inc. is the original, pioneering issuer-paidequity research firm, providing integrated research and global financialcommunications platforms for the benefit of shareholders and the Marketat-large since 1996. Investrend is privately-held, and is headquarteredin Austin, Texas, with offices in New York City.
Investrend’s Discovery Research platform is designed to provide ananalysis of the industry and industry niche that a company is operatingin, as well as an analysis of the company’s business model, includingproducts, services, pricing, cost structure, and competitive advantage.Importantly, Investrend’s Discovery Research model also focuses onidentifying any existing “catalyst” that could lead to broaderunderstanding and/or recognition of the company’s investment story onWall Street.
About The Investrend Research Syndicate:
The Investrend Research Syndicate (https://www.investrend.com/research/syndicate),a proprietary entity of Investrend Communications, Inc., distributesreports published by sources dedicated to unbiased, reliable analyticsand complete transparency. The primary measure for determining thosesources is the “Standards for Independent Research Providers” (https://www.investrend.com/FIRST/standards).
Disclosures:
CelLynx Group, Inc. (“CelLynx”) has paid Investrend Communications, Inc.(“Investrend”) six thousand US dollars to arrange for an independentanalyst to write one “Discovery” Research Report and one follow-up,Update Report on CelLynx. CelLynx’s payment to Investrend also providesthat Investrend will facilitate a “Distribution and Visibility” Programin conjunction with and in support of Investrend’s research coverage onCelLynx.
Full payment from CelLynx was (and will be) paid to Investrend prior toreceipt of any report draft(s), and therefore has been (and will be)paid in-full prior to the issuance of any final report(s). The analystwriting CelLynx’s report was (and will be) paid directly by Investrendprior to the issuance of any report draft(s) to CelLynx, and thereforehas been (and will be) paid in-full prior to the issuance of any finalreport(s); and said payment to the writing analyst is not contingent onany “positive,” “negative” or “neutral” sentiment being expressed in theanalyst’s report(s). In addition, no Investrend partner, owner, officer,employee or the analyst(s) writing regarding CelLynx holds a position inand/or engages in transactions with respect to the securities of CelLynx.
“Safe Harbor” Statement:
This announcement contains forward-looking information within themeaning of Section 21E of the Securities Exchange Act of 1934, asamended (the "Exchange Act"), including statements regarding potentialsales, the success of the company's business, as well as statements thatinclude the word "believe" or similar expressions. Such forward-lookingstatements involve known and unknown risks, uncertainties and otherfactors that may cause the actual results, performance or achievementsof CelLynx Group, Inc. to differ materially from those implied orexpressed by such forward-looking statements. Such factors include,among others, the risk factors included in reports filed with the SECunder the Exchange Act. This press release speaks as of the date firstset forth above and CelLynx Group, Inc. assumes no responsibility toupdate the information included herein for events occurring after thedate hereof. Actual results could differ materially from thoseanticipated due to factors such as the lack of capital, timelydevelopment of products and services, inability to deliver products andservices when promised, inability of potential customers to pay forordered products and services, and political and economic risks inherentin international trade.
Disclaimer:
The OTC Bulletin Board Exchange has neither approved nor acceptsresponsibility for the adequacy or accuracy of the above news release.